Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2009

Conditions

HCV Infection

Interventions

DRUG

ABT-333 Tablet

See Arm Description for more information.

DRUG

Placebo

See Arm Description for more information.

DRUG

ABT-333 Capsule

See arm description for more information

Trial Locations (1)

Site Reference ID/Investigator# 19441, Waukegan